Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Görünümler
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Daha fazla göster
Facebook Yorumları
Hiçbir yorum bulunamadı